(Q40444318)

20 September 2017

1 reference

title

Altered physiology and action of insulin-like growth factor 1 in skeletal muscle in chronic renal failure (English)

1 reference

20 September 2017

J. D. Kopple

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611259

18 June 2024

H. Ding

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611259

18 June 2024

X. L. Gao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611259

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7611259

18 June 2024

publication date

1 July 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0272638695901809?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

https://api.elsevier.com/content/article/PII:0272638695901809?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

American Journal of Kidney Diseases

18 June 2024

published in

1 reference

20 September 2017

volume

26

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

248-255

1 reference

Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Proximal muscle weakness in uremia. Case reports and review of the literature

18 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Light microscopic study of striated muscle in uremia

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Myopathy in chronic renal failure

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Muscle biopsy studies in chronically uremic patients: evidence for malnutrition

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Muscle intracellular electrolytes in patients with chronic uremia

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effects of nutrition and catabolic stress on intracellular amino acid pools in uremia

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effect of protein intake on weight gain and plasma amino acid levels in uremic rats

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat: accelerated alanine and glutamine formation and release

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effects of Reduced Renal Mass and Dietary Protein Intake on Amino Acid Release and Glucose Uptake by Rat Muscle In Vitro

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effect of uremia on nutritionally-induced variations in protein metabolism.

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Protein synthesis and degradation in skeletal muscle of chronically uremic rats.

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effect of energy intake on nutritional status in maintenance hemodialysis patients

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

In vitro inhibition of protein synthesis by dialysates of plasma from uraemic patients

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Cellular basis of insulin resistance in chronic uremia

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

The regulation of skeletal muscle alanine and glutamine formation and release in experimental chronic uremia in the rat: subsensitivity of adenylate cyclase and amino acid release to epinephrine and serotonin

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

25-hydroxycholecalciferol stimulation of muscle metabolism

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effects of glucocorticoids on muscle protein turnover in perfused rat hemicorpus

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Fat metabolism in heavy exercise

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

IGF binding proteins in growth-retarded children with chronic renal failure

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia

18 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Catabolic illness. Strategies for enhancing recovery

18 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Improvement of growth and food utilization by human recombinant growth hormone in uremia

18 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients

18 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Growth hormone treatment for patients with renal failure

18 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

The importance of exercise training in rehabilitation of patients with end-stage renal disease

18 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Regulation of protein turnover by recombinant human insulin-like growth factor-I in L6 myotube cultures

18 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats

18 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulinlike growth factor 1 production is inhibited in human sepsis

18 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Growth hormone and insulin-like growth factor I: nutritional pathophysiology and therapeutic potential

18 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Response of IGF-1 to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status

18 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulin-like growth factors: biochemistry and physiology

18 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats

18 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Therapeutic potential of insulinlike growth factor i.

18 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation

18 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells

18 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy

18 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effects of insulin-like growth factor I on renal function in normal men

18 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects

18 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats

18 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

18 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure

18 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans

18 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin

18 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins

18 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Metabolic actions of insulin-like growth factor-I in cultured hepatocytes from adult rats

18 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver

18 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody

18 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats

18 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients

18 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients

18 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Insulin-like growth factor-I (IGF-I) and IGF-binding proteins both decline in the rat during late pregnancy

18 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination.

18 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90180-9

18 June 2024

Identifiers

1 reference

20 September 2017

1 reference